Northern Trust Corp Enochian Biosciences Inc Transaction History

Northern Trust Corp

  • $709 Billion
  • Q2 2025

A detailed history of Northern Trust Corp transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Northern Trust Corp holds 214,025 shares of ENOB stock, worth $984,514. This represents 0.0% of its overall portfolio holdings.

Number of Shares
214,025
Previous 832,288 74.28%
Holding current value
$984,514
Previous $3.83 Million 74.29%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
N/A
-618,263 Reduced 74.28%
214,025 $984,000
Q1 2025

May 13, 2025
SELL
N/A
-57,069 Reduced 6.42%
832,288 $3.83 Million
Q4 2024

Feb 14, 2025
BUY
N/A
294,468 Added 49.5%
889,357 $4.09 Million
Q3 2024

Nov 13, 2024
BUY
N/A
291,413 Added 96.03%
594,889 $2.74 Million
Q2 2024

Aug 14, 2024
BUY
N/A
217,518 Added 253.05%
303,476 $1.4 Million
Q1 2024

May 14, 2024
SELL
N/A
-2,143 Reduced 2.43%
85,958 $395,000
Q4 2023

Feb 13, 2024
BUY
$4.3 - $4.7 $121,677 - $132,995
28,297 Added 47.32%
88,101 $405,000
Q3 2023

Nov 13, 2023
BUY
$0.0 - $4.46 $0 - $146,716
32,896 Added 122.25%
59,804 $266,000
Q2 2023

Aug 11, 2023
SELL
$0.4 - $1.3 $54,658 - $177,638
-136,645 Reduced 83.55%
26,908 $15,000
Q1 2023

May 15, 2023
BUY
$0.91 - $1.31 $2,126 - $3,061
2,337 Added 1.45%
163,553 $150,000
Q4 2022

Feb 13, 2023
BUY
$1.03 - $2.13 $12,030 - $24,878
11,680 Added 7.81%
161,216 $166,000
Q3 2022

Nov 14, 2022
SELL
$1.7 - $2.86 $4,202 - $7,069
-2,472 Reduced 1.63%
149,536 $271,000
Q2 2022

Aug 12, 2022
BUY
$1.93 - $8.73 $241,443 - $1.09 Million
125,100 Added 464.92%
152,008 $293,000
Q4 2021

Feb 08, 2022
SELL
$6.71 - $12.55 $8,018 - $14,997
-1,195 Reduced 4.25%
26,908 $196,000
Q2 2021

Aug 13, 2021
SELL
$2.94 - $6.79 $360,667 - $832,970
-122,676 Reduced 81.36%
28,103 $140,000
Q1 2021

May 12, 2021
SELL
$3.02 - $4.51 $30,148 - $45,023
-9,983 Reduced 6.21%
150,779 $534,000
Q4 2020

Feb 11, 2021
SELL
$2.82 - $3.55 $35,416 - $44,584
-12,559 Reduced 7.25%
160,762 $475,000
Q3 2020

Nov 16, 2020
BUY
$3.42 - $4.55 $77,435 - $103,021
22,642 Added 15.03%
173,321 $621,000
Q2 2020

Aug 14, 2020
SELL
$2.78 - $6.06 $84,670 - $184,569
-30,457 Reduced 16.81%
150,679 $634,000
Q1 2020

May 14, 2020
BUY
$2.08 - $5.41 $46,664 - $121,373
22,435 Added 14.14%
181,136 $543,000
Q4 2019

Feb 14, 2020
BUY
$3.48 - $6.75 $380,186 - $737,430
109,249 Added 220.92%
158,701 $797,000
Q3 2019

Nov 13, 2019
BUY
$3.95 - $5.72 $152,051 - $220,185
38,494 Added 351.29%
49,452 $272,000
Q2 2019

Aug 13, 2019
BUY
$4.5 - $6.99 $49,311 - $76,596
10,958 New
10,958 $49,000

Others Institutions Holding ENOB

# of Institutions
46
Shares Held
15.6M
Call Options Held
107K
Put Options Held
0
View Full List

About Enochian Biosciences Inc

ENOB Quotes by TradingView
  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email